A recent study reported that fraxinellone, a tetrahydro-benzofuranone derivative, suppresses the growth and migration of GBM cells by downregulating SIRT3 signaling in vitro and inhibits the tumorigenesis of GBM in vivo [27]. Here, SIRT3 is linked to glioblastoma.